The pharmaceutical world is witnessing a significant shift in diabetes treatment with the emergence of GLP-1 skin applications. These devices offer a seemingly more convenient alternative to subcutaneous administrations of GLP-1 medications, reducing the requirement of daily needle sticks. The te